Factors Associated with 30- and 90-Day Mortality After Percutaneous Cholecystostomy for Acute Cholecystitis: A Single-Centre Retrospective Cohort Study
Journal of Clinical Medicine · 13.08.2026 · 15 (16) · 6270
DOI: 10.3390/jcm15166270 ↗Kurz gefasst
Kohortenstudie in der Zeitschrift Journal of Clinical Medicine, online erschienen am 13.08.2026. Verfasst von Berkan Acar und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of General Surgery, Faculty of Medicine, Giresun University, 28200 Giresun, Türkiye. Die Arbeit nennt 16 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background/Objectives: Percutaneous cholecystostomy (PC) is used for acute cholecystitis when early cholecystectomy is considered unsafe. We evaluated factors associated with 30- and 90-day mortality after PC.
Methods
This single-centre retrospective cohort included 84 consecutive patients treated between December 2021 and December 2025. Clinical characteristics, comorbidity, Tokyo severity grade, intensive care unit (ICU) admission during the index episode, microbiology and admission laboratory values were analysed. Separate age-adjusted logistic models included age and one pre-specified factor at a time.
Results
The median age was 74.5 years, and 50 patients (59.5%) were male. Thirty-one patients (36.9%) had Tokyo grade III disease and 26 (31.0%) were admitted to the ICU during the index episode. The thirty-day mortality was 12/84 (14.3%; the 95% confidence interval [CI], 8.4–23.3). The crude 90-day mortality was 20/84 (23.8%; 95% CI, 16.0–33.9), and mortality among 82 patients with complete 90-day status was 20/82 (24.4%; 95% CI, 16.4–34.7). In separate age-adjusted models, ICU admission during the index episode was associated with 30-day (odds ratio [OR], 14.31; 95% CI, 2.77–73.99) and 90-day mortality (OR, 21.10; 95% CI, 5.65–78.85); Tokyo grade III disease showed corresponding associations (OR, 9.44; 95% CI, 1.84–48.35 and OR, 19.07; 95% CI, 4.74–76.66).
Conclusions
Tokyo grade III disease and ICU admission during the index episode were strongly associated with early mortality. These estimates do not demonstrate independent effects or validated predictive performance and require confirmation in larger multicentre cohorts.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of General Surgery, Faculty of Medicine, Giresun University, 28200 Giresun, Türkiye.
- General Surgery Clinic, Private Adatıp Hospital, 54050 Sakarya, Türkiye.
- General Surgery Clinic, Private Umut Hospital, 52200 Ordu, Türkiye.
- Department of General Surgery, Faculty of Medicine, Süleyman Demirel University, 32260 Isparta, Türkiye.
- School of Surgery, Yorkshire and Humber Deanery, NHS England, Leeds LS2 9JT, UK.
- Giresun Provincial Health Directorate, Bulancak Sehit Er Enver Erdogan Family Health Center, 28300 Giresun, Türkiye.
ORCID-Profile: Berkan Acar, Ali Muhtaroğlu, Elif Yılmaz, Serdar Acar, Yavuz Çekiç, Mehmet Yıldız
Zitieren
APA
Acar, B., Muhtaroğlu, A., Yılmaz, E., Acar, S., Çekiç, Y., & Yıldız, M. (2026). Factors Associated with 30- and 90-Day Mortality After Percutaneous Cholecystostomy for Acute Cholecystitis: A Single-Centre Retrospective Cohort Study. Journal of Clinical Medicine, 15(16), 6270. https://doi.org/10.3390/jcm15166270
Vancouver
Acar B, Muhtaroğlu A, Yılmaz E, Acar S, Çekiç Y, Yıldız M. Factors Associated with 30- and 90-Day Mortality After Percutaneous Cholecystostomy for Acute Cholecystitis: A Single-Centre Retrospective Cohort Study. Journal of Clinical Medicine. 2026;15(16):6270. doi:10.3390/jcm15166270
BibTeX
@article{Acar2026,
author = {Acar, Berkan and Muhtaroğlu, Ali and Yılmaz, Elif and Acar, Serdar and Çekiç, Yavuz and Yıldız, Mehmet},
title = {Factors Associated with 30- and 90-Day Mortality After Percutaneous Cholecystostomy for Acute Cholecystitis: A Single-Centre Retrospective Cohort Study},
journal = {Journal of Clinical Medicine},
year = {2026},
volume = {15},
number = {16},
pages = {6270},
doi = {10.3390/jcm15166270}
}
EUVIMED